Last reviewed · How we verify

Atopic Dermatitis — Treatment Landscape & Competitive Intelligence

Atopic Dermatitis (Dermatology) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Dermatology 10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Atopic Dermatitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Cibinqo Abrocitinib Pfizer Janus Kinase Inhibitor [EPC] Tyrosine-protein kinase JAK1 2022-01-01
Olumiant baricitinib Eli Lilly Janus Kinase Inhibitor [EPC] Tyrosine-protein kinase JAK2 2018-01-01
Dupixent DUPILUMAB Regeneron Interleukin-4 Receptor alpha Antagonist [EPC] Interleukin-4 receptor subunit alpha 2017-01-01
Eucrisa CRISABOROLE Anacor Pharms Inc Phosphodiesterase 4 Inhibitor [EPC] Phosphodiesterase 4 2016-01-01
Elidel PIMECROLIMUS Bausch Health Calcineurin Inhibitor Immunosuppressant [EPC] Peptidyl-prolyl cis-trans isomerase FKBP1A 2001-01-01
Flonase fluticasone propionate GSK (GlaxoSmithKline) Inhaled/intranasal corticosteroid Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor 1994-11-04
Prograf TACROLIMUS Astellas Pharma Calcineurin Inhibitor Immunosuppressant Interferon gamma 1994-01-01
Dermatop PREDNICARBATE Bausch Health Corticosteroid Glucocorticoid receptor 1991-01-01
Ultravate ulobetasol propionate Ranbaxy ulobetasol propionate Glucocorticoid receptor 1990-01-01
Elocon MOMETASONE FUROATE Merck & Co. Corticosteroid Progesterone receptor 1987-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 11 drugs in Atopic Dermatitis
  2. Pfizer · 8 drugs in Atopic Dermatitis
  3. Astellas Pharma · 2 drugs in Atopic Dermatitis
  4. Sun Pharma · 2 drugs in Atopic Dermatitis
  5. Merck & Co. · 2 drugs in Atopic Dermatitis
  6. Anacor Pharms Inc · 2 drugs in Atopic Dermatitis
  7. Bausch Health · 2 drugs in Atopic Dermatitis
  8. Generic (originally Schering) · 2 drugs in Atopic Dermatitis
  9. GSK (GlaxoSmithKline) · 1 drug in Atopic Dermatitis
  10. Creighton University · 1 drug in Atopic Dermatitis
  11. Fougera Pharms Inc · 1 drug in Atopic Dermatitis
  12. Fougera Pharms · 1 drug in Atopic Dermatitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Atopic Dermatitis:

Cite this brief

Drug Landscape (2026). Atopic Dermatitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/atopic-dermatitis. Accessed 2026-05-13.

Related